news Possible treatment discovered for severe dengue disease 28 August 2019 | By Rachael Harper (Drug Target Review) New findings suggest a possible new treatment strategy for severe dengue disease using the tryptase inhibitor, nafamostat mesylate.
news Succinate in cystic fibrosis lungs feeds deadly bacteria 23 August 2019 | By Rachael Harper (Drug Target Review) Targeting a deadly bacteria's use of succinate in the lungs could control infection and improve the health of people with cystic fibrosis.
news Gene linked to rare disorder also regulates key enzyme in Alzheimer’s 22 August 2019 | By Rachael Harper (Drug Target Review) A gene associated with a rare balance disorder also regulates the behaviour of an enzyme that increases the risk for Alzheimer's disease.
news Osteoporosis in mice reversed with new drug target 21 August 2019 | By Rachael Harper (Drug Target Review) A pharmaceutical target has been identified by Duke University that, when activated, can reverse bone degradation caused by osteoporosis.
news New drug target for glioblastoma identified by study 21 August 2019 | By Rachael Harper (Drug Target Review) A new drug target for treating glioblastoma has been identified from a cellular pathway found to contribute to the spread of glioma stem cells.
news Electrical channels in retina could play role in degenerative diseases 16 August 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered electrical channels important in sensory cell renewal which could be studied further to develop therapies for retinal diseases.
news New CRISPR technique could alter the way we look at brain diseases 16 August 2019 | By Fraser Owen (Drug Target Review) Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
news Genes linked to Alzheimer’s risk have been identified 15 August 2019 | By Nic Losardo (Drug Target Review) Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
news Blood-brain barrier role in Alzheimer’s patients revealed by tissue model 13 August 2019 | By Rachael Harper (Drug Target Review) A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
news Parkinson’s disease symptoms “improved” by oestrogen 13 August 2019 | By Rachael Harper (Drug Target Review) New research into sex-based differences of Parkinson's disease could lead to new treatments.
news Direct toxic action of beta-amyloid in Alzheimer’s patients identified 12 August 2019 | By Rachael Harper (Drug Target Review) The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
article Five newest developments for imaging in drug research 12 August 2019 | By Victoria Rees (Drug Target Review) Imaging methods are used by scientists to identify therapeutic targets and improve drug efficacy. This article lists five of the latest developments for imaging techniques.
news Potential treatment target identified for Crohn’s disease 9 August 2019 | By Rachael Harper (Drug Target Review) Researchers have identified a pathway in the immune system activated in Crohn's disease which could lead to investigating new treatments.
news CRISPR-Cas used to edit cystic fibrosis gene mutations 8 August 2019 | By Rachael Harper (Drug Target Review) A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
news Experimental treatment slows prion disease 5 August 2019 | By Rachael Harper (Drug Target Review) A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice
